Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point [Seeking Alpha]
Tectonic Therapeutic, Inc. (TECX)
Company Research
Source: Seeking Alpha
TECX is targeting CpcPH patients with PVR 3 in the ongoing phase 2 APEX study of PH-HFpEF, with topline data expected in 2026 and expansion into PH-ILD planned then also. TECX holds $268.4 million in cash, sufficient to fund operations into Q4 2028 and support multiple clinical milestones, including several catalysts. The pulmonary arterial hypertension market is expected to reach $9.35 billion across the 7 major markets [7MM] in 2034. FabrikaCr/iStock via Getty Images The last time I spoke about Tectonic Therapeutic, Inc. TECX ), it was in a Seeking Alpha article entitled "Tectonic: Expansion OF TX45 Candidate Possible After Positive Interim Data." In the article, I spoke about the company's More on my IG service This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subs
Show less
Read more
Impact Snapshot
Event Time:
TECX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECX alerts
High impacting Tectonic Therapeutic, Inc. news events
Weekly update
A roundup of the hottest topics
TECX
News
- Tectonic Therapeutic to Participate in December Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Tectonic Therapeutic to Participate in December Investor ConferencesGlobeNewswire
- Tectonic Therapeutic GAAP EPS of -$1.02 beats by $0.05 [Seeking Alpha]Seeking Alpha
- Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business HighlightsGlobeNewswire
- Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEFGlobeNewswire
TECX
Earnings
- 11/6/25 - Beat
TECX
Analyst Actions
- 10/20/25 - Wells Fargo & Company
TECX
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- TECX's page on the SEC website